EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A high‐fat diet supplemented with medium‐chain triglycerides ameliorates hepatic steatosis by reducing ceramide and diacylglycerol accumulation in mice

Stephanie Mourad, Abdualrahman Mohammed Abdualkader, Xiaobei Li, Shailee Jani, Rolando B Ceddia, Rami Al Batran iD

Experimental Physiology · 2024-03 · 109 (3) · 350-364

DOI: 10.1113/ep091545 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Physiology, online erschienen am 09.01.2024. Verfasst von Stephanie Mourad und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Université de Montréal, Montréal, Quebec, Canada. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Diabetes Mellitus, Type 2, Insulins, Insulin Resistance. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC), Canada Foundation for Innovation (CFI), FRQ | Fonds de Recherche du Québec - Santé (FRQS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non‐alcoholic fatty liver disease (NAFLD) is projected to be the most common chronic liver disease worldwide and is closely linked to obesity, insulin resistance and type 2 diabetes. Currently, no pharmacological treatments are available to treat NAFLD, and lifestyle modification, including dietary interventions, is the only remedy. Therefore, we conducted a study to determine whether supplementation with medium‐chain triglycerides (MCTs), containing a mixture of C8 and C10 (60/40), attenuates NAFLD in obese and insulin‐resistant mice. To achieve that, we fed C57BL/6 male mice a high‐fat diet (HFD) for 12 weeks to induce obesity and hepatic steatosis, after which obese mice were assigned randomly either to remain on the HFD or to transition to an HFD supplemented with MCTs (HFD + MCTs) or a low‐fat diet (LFD) for 6 weeks as another dietary intervention model. Another group of mice was kept on an LFD throughout the study and used as a lean control group. Obese mice that transitioned to HFD + MCTs exhibited improvement in glucose and insulin tolerance tests, and the latter improvement was independent of changes in adiposity when compared with HFD‐fed mice. Additionally, supplementation with MCTs significantly reduced hepatic steatosis, improved liver enzymes and decreased hepatic expression of inflammation‐related genes to levels similar to those observed in obese mice transitioned to an LFD. Importantly, HFD + MCTs markedly lowered hepatic ceramide and diacylglycerol content and prevented protein kinase C‐ε translocation to the plasma membrane. Our study demonstrated that supplementation with MCTs formulated mainly from C8 and C10 effectively ameliorated NAFLD in obese mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2InsulinsInsulin ResistanceMaleAnimalsMiceMice, Inbred C57BLDiet, High-FatDiglyceridesMice, ObeseDietary SupplementsObesityCeramidesLiverTriglycerides

Stichwörter der Autor:innen

ceramidediacylglycerolhepatic steatosisinflammationmedium-chain triglycerides

Substanzen

DiglyceridesCeramidesInsulinsTriglycerides

Autor:innen und Institutionen

  • Faculty of Pharmacy, Université de Montréal, Montréal, Quebec, Canada.
  • Montreal Diabetes Research Center, Montréal, Quebec, Canada.
  • Cardiometabolic Health, Diabetes and Obesity Research Network, Montréal, Quebec, Canada.
  • Muscle Health Research Center, School of Kinesiology and Health Science, York University, North York, Ontario, Canada.

ORCID-Profile: Rami Al Batran

Förderung

  • Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC)
  • Canada Foundation for Innovation (CFI)
  • FRQ | Fonds de Recherche du Québec - Santé (FRQS)
  • New Investigator of the Kidney Research Scientist Core Education and National Training (KRESCENT)

Zitieren

APA

Mourad, S., Abdualkader, A. M., Li, X., Jani, S., Ceddia, R. B., & Al Batran, R. (2024). A high‐fat diet supplemented with medium‐chain triglycerides ameliorates hepatic steatosis by reducing ceramide and diacylglycerol accumulation in mice. Experimental Physiology, 109(3), 350-364. https://doi.org/10.1113/ep091545

Vancouver

Mourad S, Abdualkader AM, Li X, Jani S, Ceddia RB, Al Batran R. A high‐fat diet supplemented with medium‐chain triglycerides ameliorates hepatic steatosis by reducing ceramide and diacylglycerol accumulation in mice. Experimental Physiology. 2024;109(3):350-364. doi:10.1113/ep091545

BibTeX
@article{Mourad2024,
  author = {Mourad, Stephanie and Abdualkader, Abdualrahman Mohammed and Li, Xiaobei and Jani, Shailee and Ceddia, Rolando B and Al Batran, Rami},
  title = {A high‐fat diet supplemented with medium‐chain triglycerides ameliorates hepatic steatosis by reducing ceramide and diacylglycerol accumulation in mice},
  journal = {Experimental Physiology},
  year = {2024},
  volume = {109},
  number = {3},
  pages = {350--364},
  doi = {10.1113/ep091545}
}
Kostenlos starten →